Republican members on the committee expressed concerns with the legislation, particularly that it would discourage innovation for new medicines in the pharmaceutical industry.
Republican members on the committee expressed concerns with the legislation, particularly that it would discourage innovation for new medicines in the pharmaceutical industry.
CNBC’s Jim Cramer explains why some stocks rallied on “not-as-bad-as-feared” quarterly reports, makes a case to speculate on positive trade deal news and says to “ring the register” on Netflix.
Jim Cramer takes calls and delivers his thoughts on the stocks of SmileDirectClub, Zebra Technologies, Boston Beer and Cedar Fair.
SpaceX now has three of its next-generation Starship rockets under construction, CNBC has learned.
“You’ve got to understand what Netflix is up against because when you look at these [quarterly] numbers in context I think they’re pretty discouraging,” CNBC’s Jim Cramer says.
You need to factor in resolutions to the trade disputes “before you start doing a lot of selling right into this market,” Jim Cramer says.
Jim Cramer breaks down why shares of Union Pacific, Honeywell and Johnson & Johnson managed to rally on mixed-earnings reports.
The decision about the monthlong strike was announced as local union leaders approved the tentative deal between the union and GM that was announced Wednesday.
IBM shares fell after its earnings as another revenue decline at the technology giant again disappointed investors. Recent trading history in IBM suggests that Big Blue is not due for a quick rebound.
Netflix’s most recent earnings report helped its stock, and it could be on a path even higher, some experts say.
